Clinical Trials

Baptist Cancer Services offers patients participation in clinical trials. Following are the clinical trials currently available. For more information, contact our Baptist Cancer Services Navigator, Tonya Ball, at 601-974-6238.

Breast Cancer

Astra Zeneca-Phase 3 randomized study of Olaparib versus physician's' choice chemotherapy in metastatic breast cancer with germline BRACA 1/2 Mutations.

Merrimack - MM302 with Herceptin in advanced metastatic breast cancer

Novartis - Randomized study of Ribociclib in combination with Faslodex for advanced breast cancer

Puma Biotechnology - Neratinib plus Xeloda versus Tykerb plus Xeloda in patients with HER 2 positive metastatic breast cancer who have received two or more regimens for metastatic disease

Colon Cancer

Sanofi - Observational trial for metastatic colon cancer patients receiving Zaltrap in combination with FOLFIRI


Novartis - a phase 3 study trial of LGYX818 and MEK 162 and  LX818 monotherapy compared with Vemurafenib in metastatic melanoma

Multiple Myeloma

Bristol Myers -  Elotuzumab with Revlimid in relapsed or refractory multiple myeloma

Myelodysplastic Syndrome

Celgene– phase 3 randomized, double-blind study to compare efficacy and safety of Oral Azacitidine versus placebo plus best supportive care in subjects with RBC transfusion dependent anemia and thrombocytopenia due to IPSS lower risk MDS 



Baptist Flame

Cancer Services Hederman Cancer Center


Find A Doctor



Baptist Medical Clinic

Patients & Visitors


Contact Us

Physician Tools

Careers at Baptist

Employee Links

Online Services

At Baptist Health Systems

At Baptist Medical Center

close ×